Wedge Capital Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Sell
64,840
-2,043
-3% -$147K 0.08% 198
2026
Q1
$4.76M Sell
66,883
-14,645
-18% -$1M 0.09% 203
2025
Q4
$4.82M Buy
81,528
+2,522
+3% +$137K 0.09% 216
2025
Q3
$4.36M Sell
79,006
-14,778
-16% -$769K 0.07% 227
2025
Q2
$4.04M Buy
93,784
+2,425
+3% +$93.5K 0.07% 229
2025
Q1
$3.62M Sell
91,359
-27,236
-23% -$1.21M 0.07% 233
2024
Q4
$4.83M Sell
118,595
-10,554
-8% -$439K 0.09% 210
2024
Q3
$5.04M Sell
129,149
-14,344
-10% -$571K 0.09% 208
2024
Q2
$6.27M Buy
143,493
+6,009
+4% +$290K 0.11% 183
2024
Q1
$6.56M Buy
137,484
+378
+0.3% +$17K 0.11% 200
2023
Q4
$6.47M Buy
137,106
+30,201
+28% +$1.25M 0.12% 205
2023
Q3
$5.09M Buy
+106,905
New +$5.84M 0.1% 221

Other funds holding NGVT

Wedge Capital Management's NGVT Position: Q2 2026 in Review

Wedge Capital Management reduced its Ingevity (NGVT) stake by 3.1% in Q2 2026, selling an estimated $147K and leaving 64,840 shares worth $4.84M. The position accounts for 0.08% of the portfolio, ranked #198.

Wedge Capital Management first reported a position in NGVT in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.56M in Q1 2024. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Wedge Capital Management held 64,840 shares of Ingevity worth $4.84M as of Q2 2026.
  • Wedge Capital Management sold 2,043 Ingevity shares in Q2 2026, an estimated $147K.
  • Ingevity made up 0.08% of Wedge Capital Management's portfolio in Q2 2026, its #198 holding.
  • Wedge Capital Management first reported a position in Ingevity in Q3 2023 and has held it in 12 quarters since.
  • Wedge Capital Management's Ingevity position peaked at $6.56M in Q1 2024.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.